Federated Hermes’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.02M | Sell |
|
|||||
|
2025
Q2 | $2.67M | Buy |
|
|||||
|
2025
Q1 | $1.39M | Buy |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $844K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $6K | Sell |
|
|||||
|
2021
Q4 | $668K | Sell |
|
|||||
|
2021
Q3 | $12.5M | Buy |
|
|||||
|
2021
Q2 | $11.8M | Buy |
|
|||||
|
2021
Q1 | $253K | Buy |
|
|||||
|
2020
Q4 | $1K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $949K | Sell |
|
|||||
|
2019
Q2 | $2.31M | Sell |
|
|||||
|
2019
Q1 | $6.34M | Buy |
|
|||||
|
2018
Q4 | $3.52M | Buy |
|
|||||
|
2018
Q3 | $11K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $385K | Sell |
|
|||||
|
2017
Q1 | $2.12M | Buy |
|
|||||
|
2016
Q4 | $531K | Buy |
|
|||||
|
2016
Q3 | $357K | Sell |
|
|||||
|
2016
Q2 | $297K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $10K | Buy |
|